DUBLIN--(BUSINESS WIRE)--The "Kidney Transplantation Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.
Kidney Transplantation Pipeline Highlights - 2017 Update provides the most up-to-date information on key pipeline products in the global Kidney Transplantation market.
It covers emerging therapies for Kidney Transplantation in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Kidney Transplantation pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Kidney Transplantation pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Kidney Transplantation pipeline products by the company.
Short-term Launch Highlights:
Find out which Kidney Transplantation pipeline products will be launched in the US and Ex-US till 2020.
Key Topics Covered:
1. Kidney Transplantation Pipeline by Stages
2. Kidney Transplantation Pipeline by Drug Class
3. Kidney Transplantation Pipeline by Company
4. Kidney Transplantation Phase 3 Clinical Trial Insights
5. Kidney Transplantation Phase 2 Clinical Trial Insights
6. Kidney Transplantation Phase 1 Clinical Trial Insights
7. Kidney Transplantation Preclinical Research Insights
8. Kidney Transplantation Discovery Stage Insights
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/g6ddtj/kidney?w=4